A Prehistoric Mural in Spain Depicting Neurotropic Psilocybe Mushrooms? Read More > February 17, 2011
Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs Read More > February 15, 2011
Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens Read More > January 20, 2011
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Read More > January 3, 2011
Exploring the impact of ketamine on the experience of illusory body ownership Read More > January 1, 2011
Characterization of behavioral and endocrine effects of LSD on zebrafish Read More > December 25, 2010
Is Ecstasy an “Empathogen”? Effects of ±3,4-Methylenedioxymethamphetamine on Prosocial Feelings and Identification of Emotional States in Others Read More > December 15, 2010
Lack of effect of sublingual salvinorin A, a naturally occurring kappa opioid, in humans: a placebo-controlled trial Read More > December 8, 2010
Human psychopharmacology and dose-effects of salvinorin A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorum Read More > December 3, 2010
Investigating the Mechanisms of Hallucinogen-Induced Visions Using 3,4-Methylenedioxyamphetamine (MDA): A Randomized Controlled Trial in Humans Read More > December 2, 2010
